microRNA (miRNA) Therapeutics: From Gene Regulation to Clinical Applications and Future Directions
DOI:
https://doi.org/10.33687/ricosbiol.01.02.103Keywords:
microRNA, miRNA therapeutics, antagomir, miRNA mimic, veterinary medicine, livestock, cattle, water buffalo, reproduction, mastitis, gene regulationAbstract
MicroRNAs (miRNAs) are endogenous, small non-coding RNAs that function as critical post-transcriptional regulators of gene expression, influencing virtually every cellular process. This review provides a comprehensive analysis of the miRNA therapeutics field, beginning with the fundamental biology of miRNA biogenesis and their mechanisms of action in gene silencing. We detail the two primary therapeutic strategies: miRNA inhibition using antisense oligonucleotides (antagomirs) and miRNA replacement using synthetic miRNA mimics. The review critically examines the significant delivery challenges and evaluates current delivery platforms including lipid nanoparticles and GalNAc conjugates (van Rooij & Kauppinen, 2014; Rupaimoole & Slack, 2017). We survey the expanding therapeutic landscape in human medicine, focusing on oncology, cardiovascular, and metabolic diseases (Hanna, Hossain, & Kocerha, 2019). A dedicated section explores the burgeoning field of miRNA applications in veterinary medicine, particularly in cattle and water buffalo, where miRNAs offer revolutionary tools for enhancing production traits (milk yield, meat quality), improving reproductive efficiency, and combating endemic diseases like mastitis and foot-and-mouth disease (Miretti et al., 2013; Ioannidis & Donadeu, 2016). Finally, we discuss challenges in specificity and delivery, while outlining future directions including species-specific design, combination therapies, and the integration of miRNA therapeutics into precision livestock farming. The dual progress in human and veterinary applications underscores miRNAs' potential as transformative therapeutic agents across species.
Downloads
References
Bader, A. G., Brown, D., & Winkler, M. (2010). The promise of microRNA replacement therapy. Cancer Research, 70 (18), 7027–7030. https://doi.org/10.1158/0008-5472.CAN-10-2010
Bartel, D. P. (2004). MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell, 116 (2), 281–297. https://doi.org/10.1016/S0092-8674(04)00045-5
Bauersachs, S., Ulbrich, S. E., Gross, K., Schmidt, S. E., Meyer, H. H., Wenigerkind, H., Vermehren, M., Sinowatz, F., Blum, H., & Wolf, E. (2009). Embryo-induced transcriptome changes in bovine endometrium reveal species-specific and common molecular markers of uterine receptivity. Reproduction, 138 (4), 579–589. https://doi.org/10.1530/REP-09-0147
Beg, M. S., Brenner, A. J., Sachdev, J., Borad, M. J., Kang, Y.-K., Stoudemire, J., Smith, S., Bader, A. G., Kim, S., & Hong, D. S. (2017). Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors. Investigational New Drugs, 35 (2), 180–188. https://doi.org/10.1007/s10637-016-0407-y
Bernstein, E., Caudy, A. A., Hammond, S. M., & Hannon, G. J. (2001). Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature, 409 (6818), 363–366. https://doi.org/10.1038/35053110
Brown, B. D., & Naldini, L. (2009). Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications. Nature Reviews Genetics, 10 (8), 578–585. https://doi.org/10.1038/nrg2628
Chakraborty, C., Sharma, A. R., Sharma, G., Lee, S.-S. (2021). The interplay among miRNAs, major cytokines, and cancer-related inflammation.Molecular Therapy - Nucleic Acids, 20, 606–620.https://doi.org/10.1016/j.omtn.2020.04.002
Croce, C. M. (2009). Causes and consequences of microRNA dysregulation in cancer. Nature Reviews Genetics, 10 (10), 704–714. https://doi.org/10.1038/nrg2634
Elmén, J., Lindow, M., Schütz, S., Lawrence, M., Petri, A., Obad, S., Lindholm, M., Hedtjärn, M., Hansen, H. F., Berger, U., Gullans, S., Kearney, P., Sarnow, P., Straarup, E. M., & Kauppinen, S. (2008). LNA-mediated microRNA silencing in non-human primates. Nature, 452 (7189), 896–899. https://doi.org/10.1038/nature06783
Geary, R. S., Norris, D., Yu, R., & Bennett, C. F. (2015). Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides. Advanced Drug Delivery Reviews, 87 , 46–51. https://doi.org/10.1016/j.addr.2015.01.008
Han, J., Lee, Y., Yeom, K.-H., Kim, Y.-K., Jin, H., & Kim, V. N. (2004). The Drosha–DGCR8 complex in primary microRNA processing. Genes & Development, 18 (24), 3016–3027. https://doi.org/10.1101/gad.1262504
Hanna, J., Hossain, G. S., & Kocerha, J. (2019). The potential for microRNA therapeutics and clinical research. Frontiers in Genetics, 10 , 478. https://doi.org/10.3389/fgene.2019.00478
Hutvágner, G., & Zamore, P. D. (2002). A microRNA in a multiple-turnover RNAi enzyme complex. Science, 297 (5589), 2056–2060. https://doi.org/10.1126/science.1073827
Ioannidis, J., & Donadeu, F. X. (2016). Circulating microRNA profiles during the bovine oestrous cycle. PLOS ONE, 11 (6), e0158160. https://doi.org/10.1371/journal.pone.0158160
Janssen, H. L., Reesink, H. W., Lawitz, E. J., Zeuzem, S., Rodriguez-Torres, M., Patel, K., van der Meer, A. J., Patrick, A. K., Chen, A., Zhou, Y., Persson, R., King, B. D., Kauppinen, S., Levin, A. A., & Hodges, M. R. (2013). Treatment of HCV infection by targeting microRNA. New England Journal of Medicine, 368 (18), 1685–1694. https://doi.org/10.1056/NEJMoa1209026
Krek, A., Grün, D., Poy, M. N., Wolf, R., Rosenberg, L., Epstein, E. J., MacMenamin, P., da Piedade, I., Gunsalus, K. C., Stoffel, M., & Rajewsky, N. (2005). Combinatorial microRNA target predictions. Nature Genetics, 37 (5), 495–500. https://doi.org/10.1038/ng1536
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005). Silencing of microRNAs in vivo with ‘antagomirs’. Nature, 438 (7068), 685–689. https://doi.org/10.1038/nature04303
Kulkarni, J. A., Witzigmann, D., Chen, S., Cullis, P. R., & van der Meel, R. (2021). Lipid nanoparticle technology for clinical translation of siRNA therapeutics. Accounts of Chemical Research, 54 (23), 4289–4300. https://doi.org/10.1021/acs.accounts.1c00550
Lawless, N., Foroushani, A. B., McCabe, M. S., O’Farrelly, C., & Lynn, D. J. (2014). Next generation sequencing reveals the expression of a unique miRNA profile in response to a Gram-positive bacterial infection. PLOS ONE, 9 (3), e91288. https://doi.org/10.1371/journal.pone.0091288
Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993). The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 75 (5), 843–854. https://doi.org/10.1016/0092-8674(93)90529-y
Lee, Y., Kim, M., Han, J., Yeom, K.-H., Lee, S., Baek, S. H., & Kim, V. N. (2004). MicroRNA genes are transcribed by RNA polymerase II. The EMBO Journal, 23 (20), 4051–4060. https://doi.org/10.1038/sj.emboj.7600385
Li, Z., Liu, H., Jin, X., Lo, L., & Liu, J. (2012). Expression profiles of microRNAs from lactating and non-lactating bovine mammary glands and identification of miRNA related to lactation. BMC Genomics, 13 , 731. https://doi.org/10.1186/1471-2164-13-731
Miretti, S., Lecchi, C., Ceciliani, F., Baratta, M., & Ponzio, P. (2013). MicroRNA expression in bovine mammary gland parenchyma infected by coagulase-positive or coagulase-negative staphylococci. Veterinary Research, 44 (1), 97. https://doi.org/10.1186/1297-9716-44-97
Pasquinelli, A. E., Reinhart, B. J., Slack, F., Martindale, M. Q., Kuroda, M. I., Maller, B., Hayward, D. C., Ball, E. E., Degnan, B., Müller, P., Spring, J., Srinivasan, A., Fishman, M., Finnerty, J., Corbo, J., Levine, M., Leahy, P., Davidson, E., & Ruvkun, G. (2000). Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature, 408 (6808), 86–89. https://doi.org/10.1038/35040556
Pillai, R. S., Bhattacharyya, S. N., Artus, C. G., Zoller, T., Cougot, N., Basyuk, E., Bertrand, E., & Filipowicz, W. (2005). Inhibition of translational initiation by Let-7 microRNA in human cells. Science, 309 (5740), 1573–1576. https://doi.org/10.1126/science.1115079
Prakash, T. P., Graham, M. J., Yu, J., Carty, R., Low, A., Chappell, A., Schmidt, K., Zhao, C., Aghajan, M., Murray, H. F., Riney, S., Booten, S. L., Murray, S. F., Gaus, H., Crosby, J., Lima, W. F., Guo, S., Monia, B. P., Swayze, E. E., & Seth, P. P. (2014). Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency 10-fold in mice. Nucleic Acids Research, 42 (13), 8796–8807. https://doi.org/10.1093/nar/gku531
Robbins, M., Judge, A., & MacLachlan, I. (2009). siRNA and innate immunity. Oligonucleotides, 19 (2), 89–102. https://doi.org/10.1089/oli.2009.0180
Rupaimoole, R., & Slack, F. J. (2017). MicroRNA therapeutics: Towards a new era for the management of cancer and other diseases. Nature Reviews Drug Discovery, 16 (3), 203–222. https://doi.org/10.1038/nrd.2016.246
Seto, A. G., Beatty, X., Lynch, J. M., Hermreck, M., Tetzlaff, M., Duvic, M., & Jackson, A. L. (2018). Cobomarsen, an oligonucleotide inhibitor of miR-155, co-ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T-cell lymphoma. British Journal of Haematology, 183 (3), 428–444. https://doi.org/10.1111/bjh.15547
Stenfeldt, C., Heegaard, P. M., Stockmarr, A., Tjørnehøj, K., & Belsham, G. J. (2014). Analysis of the acute phase responses of serum amyloid A, haptoglobin and type 1 interferon in cattle experimentally infected with foot-and-mouth disease virus serotype O. Veterinary Research, 45 (1), 66. https://doi.org/10.1186/1297-9716-45-66
Sun, J., Li, X., Li, H., Wang, Q., Li, J., & Li, Z. (2019). MicroRNA expression profiles in the longissimus dorsi muscle of Qinchuan cattle and Chinese Red Steppes cattle. Meat Science, 154 , 52–59. https://doi.org/10.1016/j.meatsci.2019.04.012
Taubel, J., Hauke, W., Rump, S., Viereck, J., Batkai, S., Poetzsch, J., Rode, L., Weigt, H., Genschel, C., Lorch, U., Theek, C., Levin, A. A., Löwe, J. M., Long, G. O., & Thum, T. (2021). Novel antisense therapy targeting microRNA-132 in patients with heart failure: Results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study. European Heart Journal, 42 (2), 178–188. https://doi.org/10.1093/eurheartj/ehaa898
Tesfaye, D., Worku, D., Rings, F., Phatsara, C., Tholen, E., Schellander, K., & Hoelker, M. (2009). Identification and expression profiling of microRNAs during bovine oocyte maturation using heterologous approach. Molecular Reproduction and Development, 76 (7), 665–677. https://doi.org/10.1002/mrd.21005
Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., Bussen, M., Galuppo, P., Just, S., Rottbauer, W., Frantz, S., Castoldi, M., Soutschek, J., Koteliansky, V., Rosenwald, A., Basson, M. A., Licht, J. D., Pena, J. T., Rouhanifard, S. H., Muckenthaler, M. U., & Engelhardt, S. (2008). MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature, 456 (7224), 980–984. https://doi.org/10.1038/nature07511
Toet, H., Piedrafita, D. M., & Spithill, T. W. (2014). Liver fluke vaccines in ruminants: Strategies, progress and future opportunities. International Journal for Parasitology, 44 (12), 915–927. https://doi.org/10.1016/j.ijpara.2014.07.011
van Rooij, E., & Kauppinen, S. (2014). Development of microRNA therapeutics is coming of age. EMBO Molecular Medicine, 6 (7), 851–864. https://doi.org/10.15252/emmm.201100899
Wu, L., Fan, J., & Belasco, J. G. (2006). MicroRNAs direct rapid deadenylation of mRNA. Proceedings of the National Academy of Sciences, 103 (11), 4034–4039. https://doi.org/10.1073/pnas.0510928103
Yi, R., Qin, Y., Macara, I. G., & Cullen, B. R. (2003). Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes & Development, 17 (24), 3011–3016. https://doi.org/10.1101/gad.1158803
Zhang, K., Zhang, Y.-J., Guo, Y., Zhou, Y., & Li, S. (2016). MicroRNA profiling of the bovine hepatic tissue in Holstein cows during the peripartal period. Journal of Dairy Science, 99 (5), 3759–3765. https://doi.org/10.3168/jds.2015-10307
Downloads
Published
Data Availability Statement
No new primary experimental datasets were generated for this review. All synthesized information, comparative tables, and schematic diagrams presented herein are available from the corresponding author upon reasonable request. The miRNA sequence data referenced in the veterinary applications section are publicly accessible through the miRBase database (www.mirbase.org) under accession numbers corresponding to Bos taurus and Bubalus bubalis. Clinical trial data mentioned are available via ClinicalTrials.gov identifiers provided in the relevant citations.
Issue
Section
Categories
License
Copyright (c) 2026 Hussein Abouelhag
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/ by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http:// creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
